Harrow, Inc. (HROW)
NASDAQ: HROW · Real-Time Price · USD
28.95
-1.18 (-3.92%)
Feb 21, 2025, 4:00 PM EST - Market closed
Harrow Employees
Harrow had 315 employees as of December 31, 2023. The number of employees increased by 98 or 45.16% compared to the previous year.
Employees
315
Change (1Y)
98
Growth (1Y)
45.16%
Revenue / Employee
$536,946
Profits / Employee
-$106,051
Market Cap
1.03B
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 440,000 |
Johnson & Johnson | 131,900 |
Thermo Fisher Scientific | 122,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 72,000 |
HROW News
- 5 days ago - I Am Loading Up Big Dividends For My Golden Years - Seeking Alpha
- 26 days ago - Harrow Partners with Cencora to Launch “Harrow Cares” Program, Making IHEEZO® and TRIESENCE® More Accessible and Affordable for Retina Specialists and Their Patients - Business Wire
- 6 weeks ago - Harrow Appoints Amir H. Shojaei as Chief Scientific Officer - Business Wire
- 7 weeks ago - Those Derisked Baby Bonds Of Harrow, Inc. - Seeking Alpha
- 2 months ago - Harrow: The Triesence Relaunch - Seeking Alpha
- 3 months ago - Harrow's ImprimisRx Subsidiary Receives $34.9 Million Unanimous Jury Verdict Award in ImprimisRx, LLC v. OSRX, Inc. - Business Wire
- 3 months ago - Harrow Announces Participation in Upcoming Investor Conferences - Business Wire
- 3 months ago - Harrow, Inc. (HROW) Q3 2024 Earnings Call Transcript - Seeking Alpha